Companies / DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc.
Nasdaq: DMACCIK 1401040MINNEAPOLIS, MN
Financials
Ownership
53.9M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 1.01% | 544,499 |
| Institutions | 23.71% | 12,784,019 |
| Public float | 75.28% | 40,597,179 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Giuffre Randall MichaelDirector | 0.74% | 398,587 |
Parsons James T.Director | 0.18% | 97,949 |
Semba Charles PaulingDirector | 0.09% | 47,963 |
Kellen ScottCFO & Secretary | — | — |
Krop JulieChief Medical Officer | — | — |
Kuntz RichardDirector | — | — |
Lewis TanyaDirector | — | — |
O'Connor Daniel J.Director | — | — |
Pauls Dietrich JohnCEOPresident & CEO · Director | — | — |
Institutional holders 98
View all →| Holder | Value | % of shares |
|---|---|---|
| $16.08M | 3.75% | |
| $15.86M | 4.18% | |
| $6.33M | 1.73% | |
| $5.92M | 1.62% | |
| $5.76M | 1.34% | |
| $5.29M | 1.45% | |
| $4.55M | 1.20% | |
| $4.36M | 1.02% | |
| $3.22M | 0.75% | |
| $3.04M | 0.71% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $2.47M | +351K +18.49% | 2,252,285 4.18% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Add | Common Stock | $1.13M | +167K +21.73% | 935,592 1.73% of shares | low |
| Q4 2025 as of | Cantor Fitzgerald, L. P. 13F manager | Exit | Common Stock | $-687.0K | -100K -100.00% | 0 | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | New | Common Stock | $355.6K | +53K | 52,523 0.10% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Exit | Common Stock | $-256.3K | -32K -100.00% | 0 | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | Add | Common Stock | $255.9K | +36K +18.44% | 233,500 0.43% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | Trim | Common Stock | $-225.6K | -34K -58.97% | 23,343 0.04% of shares | low |
| Q2 2026 as of | Quadrature Capital Ltd 13F manager | Exit | Common Stock | $-187.6K | -24K -100.00% | 0 | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Trill AB | Passive13G/A | — |
| Dialectic Life Sciences SPV LLC | Passive13G/A | — |
| Cooperman Leon G | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| DMAC | Common Stock | 25253X207 |